IHH could pay up to $1.47b for controlling stake in Fortis Healthcare | Healthcare Asia Magazine
, India

IHH could pay up to $1.47b for controlling stake in Fortis Healthcare

It was chosen as the bidder to buy the controlling stake at 31.1% to 57.1%.

IHH Healthcare Berhad (IHH) subsidiary Northern TK Venture (Northern TK) was chosen as the bidder to acquire a minimum 31.1% and maximum 57.1% controlling stake in Fortis Healthcare Limited (Fortis Healthcare) at an offer of $797.71m to $1.47b (INR40b to INR73.5b).

The preferential allotment following this will make IHH the largest shareholder in Fortis Healthcare and would trigger the requirement to make a required open offer to the public shareholders of Fortis Healthcare for 26% of the outstanding shares, under the applicable provisions of Indian takeover code.

The offer price represents a 22.3x multiple of Fortis Healthcare’s EBITDA for the last twelve months ended 31 March 2018.

Upon the acquisition, IHH will have the mandatory offer to buy 26% of Fortis Healthcare subsidiary, Fortis Malar Hospital, for INR 58 per share under the applicable provisions of Indian takeover code. Fortis Malar is a group of multi super-speciality corporate hospitals in Chennai providing medical care across multiple segments.

Fortis Healthcare is the second largest hospital chain in India. It operates a network of 34 hospitals across the country and internationally with a capacity of over 4,600 beds and employs more than 2,600 doctors and 13,200 support staff that catered to around 2.6 million patients in FY2018. The deal marks the significant expansion of IHH’s exposure to India, its fourth home market.

Fortis Healthcare’s hospitals have a stronger presence in North India, complementary to IHH’s existing South India-focused portfolio and provide access to a leading platform with pan-India presence, the company said.

The deal will also mean a significant equity infusion in Fortis Healthcare to address the immediate funding requirement for operations and strategic transactions. 

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.